🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for AKI

Caffeine for Hypoxic Ischemic Encephalopathy NCT06855108Phase 37 sites📍 Saidpur📍 Kinshasa📍 Chimaltenango NICHD Global Network for Women's and Children's Health · Tests: Caffeine citrate oral solution, Oral placebo solution To Compare the Efficacy and Safety of Using oXiris and M100 During CRRT NCT06440759NA1 site📍 Kubang Kerian Mohd Zulfakar Mazlan, MBBS · Tests: oXiris filter, M100 filter Hamburg Acute Kidney Injury Study (HAKIS) NCT07338669n/a1 site📍 Hamburg Universitätsklinikum Hamburg-Eppendorf Efficacy and Safety of SP16 in Preventing Acute Kidney Injury in At-risk Subjects With Chronic Kidney Disease Undergoing Elective Cardiac Surgery Using the Heart-lung-machine NCT07661940Phase 21 site📍 Erlangen University of Erlangen-Nürnberg Medical School · Tests: SP16-3M, Placebo Mechanisms of Acute Kidney Injury in Severe Infections NCT06372444n/a1 site📍 Uppsala Uppsala University Hospital · Tests: Positron emission tomography (PET) A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial NCT05805709NA9 sites📍 Birmingham📍 New Haven📍 Weston University of Pittsburgh · Tests: Study Physician/Advance Practice Provider, Nurse Navigator, Pharmacist, Patient Education VExUS in Ards Patients and Association with AKI NCT06805409n/a1 site📍 Créteil Assistance Publique - Hôpitaux de Paris Infliximab for Immune Checkpoint Inhibitor Associated AKI NCT07683975Phase 43 sites📍 Boston📍 Boston📍 Boston Massachusetts General Hospital · Tests: Infliximab, Prednisone, prednisone (oral) Application of CLCVP Technique in Early Intervention of CSA-AKI NCT05855954NA1 site📍 Nanjing Nanjing First Hospital, Nanjing Medical University · Tests: controlled low central venous pressure technique (CLCVP) Outpatient Recovery From Acute Kidney Injury Requiring Dialysis - 2 NCT07106151NA1 site📍 San Francisco University of California, San Francisco · Tests: Transmission of additional AKI-D recovery information, No additional AKI-D recovery information Epidemiology and Processes of Care for Renal Replacement Therapy in Acute Kidney Injury in Latin America NCT07262320n/a15 sites📍 Cochabamba📍 Bahia📍 Porto Alegre University of Alabama at Birmingham Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support NCT06840210n/a1 site📍 Baltimore Johns Hopkins University Pharmacokinetics Vancomycin CVVHDF with OXiris Membrane NCT06543940NA1 site📍 Bangkok Mahidol University · Tests: Vancomycin COordiNated CommuNication, Education, and Care Transitions After Acute Kidney Injury (CONNECT-AKI) NCT07626268NA2 sites📍 Glen Oaks📍 Manhasset Northwell Health · Tests: AKI Discharge Summary Template, Chat-Based Educational Messaging Program Safety Evaluation of Prismocitrate 18 in Patients Receiving CRRT NCT05399537Phase 314 sites📍 Birmingham📍 Los Angeles📍 Los Angeles Vantive Health LLC · Tests: Prismocitrate 18, PrisMax System Version 3.x with calcium line accessory The Vancomycin Piperacillin/Tazobactam (VPT) Patient Safety Trial (VPS) NCT07556107Phase 47 sites📍 Worcester📍 Omaha📍 Cooperstown Bassett Healthcare · Tests: Piperacillin + Tazobactam, meropenem NO During CPB in Neonates to Reduce Risk of AKI NCT04216927Phase 31 site📍 Cincinnati Children's Hospital Medical Center, Cincinnati · Tests: Nitric Oxide, Oxygen AKI Risk Factors Analysis After Intentional Hypotensive Anesthesia NCT06259760n/a1 site📍 Kaohsiung City Kaohsiung Medical University Chung-Ho Memorial Hospital · Tests: Nitroglycerin Post-Cardiac Surgery Acute Kidney Injury Prevention by Administration of Proton Pump Inhibitor (P2 Trial) NCT06706258Phase 21 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Protonix (Pantoprazole) 40 mg q 12 hrs for 3 days, Pepcid (Famotidine) 20 mg q 12 hrs for 3 days LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery NCT05879432Phase 29 sites📍 Calgary📍 New Westminster📍 Toronto Arch Biopartners Inc. · Tests: LSALT Peptide, Placebo NIRS Monitoring in the NICU and AKI NCT07222722NA1 site📍 New York NYU Langone Health · Tests: NIRS Monitoring Reducing Cardiac-surgery Associated Acute Kidney Injury Occurence by Administering Angiotensin II NCT06615102Phase 34 sites📍 Berlin📍 Bonn📍 Mainz Universität Münster · Tests: Angiotensin II, Noradrenalin MAGIC AKI: Magnesium for the Prevention of HIOC-Associated AKI NCT05730816Phase 21 site📍 Boston Brigham and Women's Hospital · Tests: Magnesium sulfate, Normal Saline Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms. NCT05147831NA1 site📍 Galveston The University of Texas Medical Branch, Galveston · Tests: Remote Ischemic Preconditioning Use of EBPT in Critically Ill Patients With AKI and/or Multiorgan Failure NCT04033224n/a15 sites📍 Empoli📍 Lido di Camaiore📍 Rozzano Careggi Hospital · Tests: Commercial membrane for Extracorporeal Blood Purification Therapy (EBPT) Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patients NCT06531642Phase 2, Phase 31 site📍 Houston The University of Texas Health Science Center, Houston · Tests: Protonix (Pantoprazole) 40 mg q 12 hrs for 2 days, Protonix (pantoprazole) 40 mg q 24 hrs for 2 days Precision Medicine in Cardiovascular Surgery Associated Acute Kidney Injury NCT06471621n/a1 site📍 Bern Insel Gruppe AG, University Hospital Bern Urine Output Response to Fluid and Diuretic Therapy in Cardiac ICU Patients Monitored With FIZE kUO® NCT07022314n/a1 site📍 Petah Tikva FIZE Medical ltd · Tests: FIZE kUO® The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1 NCT06030843Phase 2, Phase 31 site📍 Bangkok Chulalongkorn University · Tests: Empagliflozin 10 MG, Placebo Genetics in the Progression of Nephropathies NCT06416761n/a1 site📍 Milan Ospedale San Raffaele · Tests: genetic polymorphisms
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy